FY2025 EPS Estimates for ACAD Raised by Cantor Fitzgerald
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Research analysts at Cantor Fitzgerald upped their FY2025 EPS estimates for shares of ACADIA Pharmaceuticals in a research report issued on Thursday, May 1st. Cantor Fitzgerald analyst C. Duncan now expects that the biopharmaceutical company will post earnings per share of $0.59 for the year, up from […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Research analysts at Cantor Fitzgerald upped their FY2025 EPS estimates for shares of ACADIA Pharmaceuticals in a research report issued on Thursday, May 1st. Cantor Fitzgerald analyst C. Duncan now expects that the biopharmaceutical company will post earnings per share of $0.59 for the year, up from […]
